Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced fourth-quarter 2023 financial results, reporting lower revenues and net income. The…
Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday announced fourth-quarter 2023 financial results, reporting higher adjusted earnings, despite a decrease…
Healthcare company DexCom, Inc. (NASDAQ: DXCM) announced preliminary results for the fourth quarter of 2023, reporting an estimated double-digit increase…